ArticleCellular oncology (Dordrecht, Netherlands)2015

Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts.

Armin Maier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.